Tay-Sachs Disease Market, By Disease Type (Infantile Tay-Sachs Disease, Juvenile Tay-Sachs Disease, and Late-Onset Tay-Sachs Disease), By Treatment Type (Gene Therapy, N-Acetyl-L-Leucine, Venglustat (substrate Reduction Therapy), and Other Pipeline Drugs/Therapy), By Route of Administration (Oral, Parenteral, and Others), By End User (Hospitals and Specialty Neurology Clinics, Diagnostic Laboratories and Genetic Centers, Research and Academic Institutes, Homecare Settings, and Patient Support Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
선택하다 귀사의 비즈니스 요구 사항에 맞는 라이센스 유형
US$ 2,200
이천이백 달러
단일 사용자 라이센스
( 전체 보고서 )
US$ 4,500
US$ 3,000
Three thousand dollars
자주 구매되는 상품
다중 사용자 라이센스
(전체 보고서)
US$ 7,000
US$ 5,000
Five thousand dollars
기업 사용자 라이센스
(전체 보고서)
US$ 10,000
US$ 6000
Six thousand dollars
Client Testimonials
Client Testimonials
우리의 고객